ARTICLE | Company News
XTL and Hybrigenics in HCV deal
September 5, 2000 7:00 AM UTC
XTL (Rehovot, Israel) and Hybrigenics (Paris, France) will develop therapeutics to treat hepatitis C virus (HCV) infection. Hybrigenics will use its PIMRider proteomics and bioinformatics platform to ...